By Unknown Author
The investigation is related to Martin Shkreli’s time as a hedge fund manager and running the biopharmaceutical company Retrophin.
Published: December 17, 2015 at 12:00AM
from NYT Business Day http://ift.tt/1Ze8Rvw
from WordPress http://ift.tt/1Rr680x
via Hadi Aboukhater
No comments:
Post a Comment